Skip to main content
. 2020 Jun 7;12(6):1489. doi: 10.3390/cancers12061489

Table 3.

Ongoing Clinical Trials.

Clinical Trial ID Disease Condition Study Phase Combination Drugs Status at Time of Search
NCT00444015 Stage IIIB/IV disease Recurrent NSCLC Phase I Erlotinib + Dasatinib Completed
NCT02954523 EGFR mut NSCLC Phase I/II Dasatinib + osimertinib Active, not recruiting
NCT00996723 Diffuse Intrinsic Pontine Glioma Phase I Vandetanib + dasatinib Completed